16 RCCA New Jersey Physicians Recognized as 2023 Top Cancer Doctors

They also benefit from choosing a location that is close to home, easing the burden of patients and families who would rather not travel to New York or Philadelphia for the same care. Being treated close also means family and friends are able to provide support and strength so that patients can focus on healing. Additionally, a Journal of Clinical Oncology showed that receiving cancer care close to home reduces hospitalizations.

The physicians named to Castle Connolly’s prestigious list of 2023 Top Cancer Doctors in New Jersey are:

• May Abdo-Matkiwsky, DO, serving the Sparta community
• Kaleen Ahmad, MD, serving the Cape May Court House/Marmora community
• Seth Berk, MD, serving the Moorestown community
• Maurice Cairoli, MD, serving the Moorestown community
• Jumana Chatiwala, MD, serving the Sparta community
• Michele Donato, MD, serving the Hackensack community
• Denis Fitzgerald, MD, serving the Little Silver community
• Andre Goy, MD, serving the Hackensack community
• Harry Harper, MD, serving the Hackensack community
• Anthony Ingenito, MD, serving the Hackensack community
• Andrew Jennis, MD, serving the Hackensack/North Bergen community
• James Lee, MD, serving the Moorestown community

• Mark Pascal, MD, serving the Hackensack community

• Andrew Pecora, MD, serving the Hackensack/North Bergen community
• Stanley Waintraub, MD, serving the Hackensack community
• Stephen Wallace, MD, serving the Moorestown community

There are more than 850,000 practicing physicians in the U.S., but only 7% are named to the Top Doctors list. The recognition is given following a comprehensive review process conducted by an experienced medical review board. Reviewers consider a doctor’s skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.

RCCA has more than 90 cancer specialists who treat patients at more than 20 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians.

RCCA is the top choice of many patients due to the comprehensive services offered by its physicians, including the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously-administered medications.

To learn more about RCCA, call 844-928-0089 or visit RCCA.com.